Search
for
Sort by
Research 241–270 of 1000+
- YKL-40 a sensitive biomarker for early androgenetic alopecia and early hidden metabolic syndrome
- Cytokinin improves in vitro organogenesis, biological activities and blooming in Vitex negundo L. - An endangered medicinal plant
- A Study of Prevalence of Metabolic Syndrome in Premenopausal Women With Female Pattern Hair Loss: A Case-Control Study
- The association between androgenic alopecia severity and the development of metabolic syndrome in Saudi Arabia: A case-control study
- Comparative clinical assessment of 5% minoxidil topical application with supplemental intradermal meso-solution administration for the management of androgenetic alopecia in men
- Topical retinoids: role and place in acne therapy
- Identifying the Active Components and Mechanisms of Persicae Semen in Treating Androgenetic Alopecia: Insights from Network Pharmacology and Experimental Evaluations
- Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC–ESI–ion trap-mass spectrometry
- A concise review- Development of an analytical method and validation of dutasteride
- Differential impact of environmental factors on systemic and localized autoimmunity
- The Physical Properties of Hair Fibers
- Mycobacteriosis in a Pet Ferret (Mustela putorius furo) Caused by Mycobacterium xenopi: A Case Report on Neglected Risk of Zoonotic Transmission
- A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma
- Simultaneous determination of seven prohibited substances in cosmetic products by liquid chromatography–tandem mass spectrometry
- Measurement of tamsulosin in human serum by liquid chromatography–tandem mass spectrometry
- Hair today, gone tomorrow: the degradation and conservation of archaeological hair fibers
- Dermatologic Manifestations in Patients with Metabolic Syndrome in Brazil
- Toxic Epidermal Necrolysis
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Leave the Fat, Skip the Bolster: Thinking outside the Box in Lower Third Nasal Reconstruction
- Comparative study of the chemical profile, cytotoxic activity, and molecular docking of Serenoa repens extract and a pharmaceutical product
- Potential Lipolytic Effect of Panduratin A Loaded Microspicule Serum as a Transdermal Delivery Approach for Subcutaneous Fat Reduction
- Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study
- PRP VS GFC: COMPARATIVE EVALUATION IN HAIR LOSS TREATMENT
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- PCOS in Adolescence and Type 2 Diabetes
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis